FindTrial
Sign In

The establishment of clinical protocol for Ultraviolet A rush hardening in the treatment of photodermatosis

The clinical effect of Ultraviolet A rush hardening for the treatment of photodermatosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017608
Enrollment
Unknown
Registered
2018-08-06
Start date
2017-01-01
Completion date
Unknown
Last updated
2019-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Photodermatosis

Interventions

Case series:UVA phototherapy

Sponsors

Dermatology Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: The patient diagnosed as photodermatosis by clinical and phototesting of minimal erythema dose (MED) in UVB and UVA,age from 18 to 70 years male or female.

Exclusion criteria

Exclusion criteria: Patients were excluded if they were pregnancy or lactation,had precancerous skin disease or skin cancerous, had received systemic immunosuppressive therapy or had serious hepatic and renal disease. Patients with a history of photosensitivity or unable to adhere to treatment were excluded.

Design outcomes

Primary

MeasureTime frame
disease severity index scores;phototesting;recurrence rate;—

Secondary

MeasureTime frame
patient satisfaction;—

Countries

China

Contacts

Public ContactHuizhong Li

Dermatology Hospital of Southern Medical University

lhz618@126.com+86 13580547320

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026